Dr. Foods, Inc. Logo

Dr. Foods, Inc.

DRFS

(1.2)
Stock Price

0,04 USD

-4472.33% ROA

-307.1% ROE

-1.97x PER

Market Cap.

5.551.105,00 USD

0% DER

0% Yield

-3719.57% NPM

Dr. Foods, Inc. Stock Analysis

Dr. Foods, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Dr. Foods, Inc. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (0%), which means it has a small amount of debt compared to the ownership it holds

2 Revenue Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

3 Net Profit Growth

This company's net profit has consistently grown over the past three years, showcasing a positive financial trend and making it an appealing investment opportunity.

4 Assets Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

5 ROE

The stock's ROE indicates a negative return (-59.63%) on shareholders' equity, suggesting poor financial performance.

6 ROA

The stock's ROA (-49.19%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

7 PBV

The stock's high Price-to-Book Value (P/BV) ratio (7.77x) suggests it's overvalued, potentially making it an expensive investment.

8 Graham Number

The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Dr. Foods, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Dr. Foods, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Dr. Foods, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Dr. Foods, Inc. Revenue
Year Revenue Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 19.675 100%
2014 142.136 86.16%
2015 96.993 -46.54%
2016 240.945 59.74%
2017 40.726 -491.62%
2021 0 0%
2022 0 0%
2023 1.038 100%
2024 20.588 94.96%
2024 15.921 -29.31%
2025 22.096 27.95%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Dr. Foods, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2007 149.288
2008 5.623 -2554.95%
2009 15.059 62.66%
2010 16.498 8.72%
2011 0 0%
2012 0 0%
2013 0 0%
2014 20.209 100%
2015 25.719 21.42%
2016 41.536 38.08%
2017 5.523 -652.06%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%
2024 0 0%
2025 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Dr. Foods, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2007 0
2008 0 0%
2009 1.206.421 100%
2010 569.536 -111.83%
2011 314.032 -81.36%
2012 71.381 -339.94%
2013 1.469.590 95.14%
2014 2.470.439 40.51%
2015 2.547.714 3.03%
2016 2.063.663 -23.46%
2017 738.921 -179.28%
2021 69.120 -969.04%
2022 1.047.108 93.4%
2023 326.423 -220.78%
2024 312.224 -4.55%
2024 274.581 -13.71%
2025 352.032 22%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Dr. Foods, Inc. EBITDA
Year EBITDA Growth
2007 -553.013
2008 -371.963 -48.67%
2009 -1.221.480 69.55%
2010 -604.784 -101.97%
2011 -332.782 -81.74%
2012 -64.806 -413.5%
2013 -1.462.678 95.57%
2014 -2.414.125 39.41%
2015 -2.496.692 3.31%
2016 -1.943.572 -28.46%
2017 -847.943 -129.21%
2021 0 0%
2022 -1.047.108 100%
2023 -325.385 -221.81%
2024 -291.636 -11.57%
2024 -766.370 61.95%
2025 -329.936 -132.28%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Dr. Foods, Inc. Gross Profit
Year Gross Profit Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 -335 100%
2012 -121 -176.86%
2013 6.829 101.77%
2014 45.982 85.15%
2015 37.590 -22.33%
2016 91.239 58.8%
2017 12.890 -607.83%
2021 0 0%
2022 0 0%
2023 1.038 100%
2024 20.588 94.96%
2024 15.922 -29.31%
2025 22.096 27.94%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Dr. Foods, Inc. Net Profit
Year Net Profit Growth
2007 -567.699
2008 -387.985 -46.32%
2009 -1.284.584 69.8%
2010 -624.114 -105.83%
2011 -270.022 -131.13%
2012 -63.114 -327.83%
2013 -1.532.710 95.88%
2014 -2.474.256 38.05%
2015 -4.811.040 48.57%
2016 -2.009.466 -139.42%
2017 -2.273.472 11.61%
2021 -69.120 -3189.17%
2022 -1.047.108 93.4%
2023 -321.820 -225.37%
2024 -287.276 -12.02%
2024 -761.837 62.29%
2025 -325.244 -134.24%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Dr. Foods, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2007 -21
2008 -13 -53.85%
2009 -35 62.86%
2010 -13 -191.67%
2011 -4 -300%
2012 0 0%
2013 -3 100%
2014 -4 25%
2015 -8 50%
2016 -3 -300%
2017 -1 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%
2024 0 0%
2025 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Dr. Foods, Inc. Free Cashflow
Year Free Cashflow Growth
2007 -450.546
2008 -181.583 -148.12%
2009 -329.998 44.97%
2010 -122.441 -169.52%
2011 -2.541 -4718.61%
2012 -79.904 96.82%
2013 -743.827 89.26%
2014 -924.728 19.56%
2015 -748.743 -23.5%
2016 -487.534 -53.58%
2017 -186.097 -161.98%
2021 -24.120 -671.55%
2022 -43.858 45%
2023 -293.628 85.06%
2024 -18.330 -1501.9%
2024 -256.940 92.87%
2025 -75.921 -238.43%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Dr. Foods, Inc. Operating Cashflow
Year Operating Cashflow Growth
2007 -391.026
2008 -159.565 -145.06%
2009 -297.229 46.32%
2010 -121.021 -145.6%
2011 -2.541 -4662.73%
2012 -79.904 96.82%
2013 -727.746 89.02%
2014 -920.648 20.95%
2015 -733.415 -25.53%
2016 -484.964 -51.23%
2017 -168.239 -188.26%
2021 -24.120 -597.51%
2022 -43.858 45%
2023 -293.628 85.06%
2024 -18.330 -1501.9%
2024 -256.940 92.87%
2025 -75.921 -238.43%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Dr. Foods, Inc. Capital Expenditure
Year Capital Expenditure Growth
2007 59.520
2008 22.018 -170.32%
2009 32.769 32.81%
2010 1.420 -2207.68%
2011 0 0%
2012 0 0%
2013 16.081 100%
2014 4.080 -294.14%
2015 15.328 73.38%
2016 2.570 -496.42%
2017 17.858 85.61%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%
2024 0 0%
2025 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Dr. Foods, Inc. Equity
Year Equity Growth
2007 -23.321
2008 -196.156 88.11%
2009 -118.824 -65.08%
2010 -448.582 73.51%
2011 -148.346 -202.39%
2012 105.473 240.65%
2013 -249.544 142.27%
2014 59.814 517.2%
2015 -2.847.875 102.1%
2016 -2.214.435 -28.61%
2017 -2.684.487 17.51%
2021 -3.750 -71486.32%
2022 -7.000 46.43%
2023 502.055 101.39%
2024 -28.413 1866.99%
2024 540.698 105.25%
2025 -32.023 1788.47%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Dr. Foods, Inc. Assets
Year Assets Growth
2007 72.034
2008 89.150 19.2%
2009 153.610 41.96%
2010 680 -22489.71%
2011 346 -96.53%
2012 384.825 99.91%
2013 216.872 -77.44%
2014 268.630 19.27%
2015 293.138 8.36%
2016 136.374 -114.95%
2017 103.783 -31.4%
2021 0 0%
2022 0 0%
2023 542.178 100%
2024 21.606 -2409.39%
2024 592.880 96.36%
2025 17.324 -3322.3%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Dr. Foods, Inc. Liabilities
Year Liabilities Growth
2007 95.355
2008 285.306 66.58%
2009 272.434 -4.72%
2010 449.262 39.36%
2011 148.692 -202.14%
2012 279.352 46.77%
2013 466.416 40.11%
2014 208.816 -123.36%
2015 3.141.013 93.35%
2016 2.350.809 -33.61%
2017 2.788.270 15.69%
2021 3.750 -74253.87%
2022 7.000 46.43%
2023 40.122 82.55%
2024 50.019 19.79%
2024 52.182 4.15%
2025 49.347 -5.75%

Dr. Foods, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.03
Price to Earning Ratio
-1.97x
Price To Sales Ratio
266.5x
POCF Ratio
-4.85
PFCF Ratio
-17.65
Price to Book Ratio
-47.68
EV to Sales
266.11
EV Over EBITDA
-7.11
EV to Operating CashFlow
-17.62
EV to FreeCashFlow
-17.62
Earnings Yield
-0.51
FreeCashFlow Yield
-0.06
Market Cap
0,01 Bil.
Enterprise Value
0,01 Bil.
Graham Number
0.03
Graham NetNet
-0

Income Statement Metrics

Net Income per Share
-0.03
Income Quality
0.41
ROE
-3.07
Return On Assets
-44.72
Return On Capital Employed
-293.37
Net Income per EBT
1
EBT Per Ebit
0.99
Ebit per Revenue
-37.41
Effective Tax Rate
-0

Margins

Sales, General, & Administrative to Revenue
14.03
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
1
Operating Profit Margin
-37.41
Pretax Profit Margin
-37.17
Net Profit Margin
-37.2

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
-0.51
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.01
Free CashFlow per Share
-0.01
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
24.35
Return on Tangible Assets
-44.72
Days Sales Outstanding
101.39
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
3.6
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
-0
Shareholders Equity per Share
-0
Interest Debt per Share
0
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0.01
Current Ratio
0.35
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
-32023
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Dr. Foods, Inc. Dividends
Year Dividends Growth

Dr. Foods, Inc. Profile

About Dr. Foods, Inc.

Dr. Foods, Inc. imports, resells, develops, and manufactures various food products. The company was incorporated in 2021 and is based in Tokyo, Japan.

CEO
Mr. Koichi Ishizuka
Employee
1
Address
K’s Minamiaoyama
Tokyo, 107-0062

Dr. Foods, Inc. Executives & BODs

Dr. Foods, Inc. Executives & BODs
# Name Age
1 Mr. Koichi Ishizuka
Chief Executive Officer & Director
70

Dr. Foods, Inc. Competitors